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FREGLY, M. J., N. E. ROWLAND AND J. E. GREENLEAF. Effects ofyohimbine and tolazoline on isoproterenol and
angiotensin ll-induced water intake in rats. BRAIN RES BULL 10(I)121-126, 1983.--Subcutaneous administration of the
_:-adrenoreceptor antagonists, yohimbine and tolazoline, at doses up to 1000 _g/kg, had no effect on water intake of female
rats. However, when these compounds were administered SC in combination with either the/3-adrenoreceptor agonist,
isoproterenol (10 to 25 ag/kg, SC), or with angiotensin Ii (200 #g/kg, SC), water intake was enhanced. In contrast,
intraventricular administration of either tolazoline (10 and 20 #g/kg) or yohimbine (300 p.g/kg) failed to augment the
dipsogenic response to angiotensin II ( 150 #g/kg, SC). Thus, the enhancing effect of these a:-adrenoreceptor antagonists on
isoproterenol- and angiotensin ll-induced water intakes appears to be manifesled peripherally, rather than centrally. In
view of the fact that clonidine, an o_-adrenoreceptor agonist, has been shown to inhibit water intake induced by both
isoproterenol and angiotensin I1, the results suggest that the a:-adrenoreceptor may play a role in modulating water intake
induced by these two dipsogenic agents.
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ACUTE administration of clonidine, an a_-adrenergic
agonist, inhibited the response to a number of dipsogenic
stimuli including isoproterenol, 5-hydroxytryptophan,
pilocarpine, hypertonic saline and dehydration [2, 3, 12]. The
possibility exists that clonidine may exert its effect on water
intake by virtue of its oL.,-adrenergic agonistic activity. The
objective of the studies described here was to determine the
effect of peripheral administration of two az-adrenoreceptor
blockers, yohimbine and tolazoline, on water intake of rats
administered isoproterenol and angiotensin I1 subcutane-
ously. In addition, the effect of centrally administered to-
lazoline and yohimbine on the dipsogenic effect of periph-
erally administered angiotensin II was tested. If a2-
adrenoreceptors play a role in the response to dipsogenic
stimuli, then blockade of these receptors should result in
effects on drinking opposite to those observed when the a2-
adrenoreceptors are stimulated by clonidine. The results
suggest that peripherally, but not centrally, administered
blockers amplified the dipsogenic effects of angiotensin I1.
GENERAL METHOD
Naive female rats of the Blue Spruce Farms (Sprague
Dawley) strain were used. They were kept three per cage in a
room maintained at 26-+ I°C and illuminated from 6 a.m. to
6 p.m. All rats received Purina Laboratory Chow and tap
water ad lib prior to the studies.
At the beginning of each study (9 a.m.) the rats were di-
vided randomly into the appropriate groups, and weighed.
The compounds to be tested were then administered. Each
rat was placed in a cage by itself without food and given a
preweighed bottle of distilled water (26°C). Water intake was
then measured hourly for the next two hours by weighing
each bottle to the nearest 0. l g. The fluid containers con-
sisted of infant nursing bottles with cast bronze fountains [5].
EXPERIMENT I: EFFECT OF YOHIMBINE ALONE, AND IN
COMBINATION WITH ISOPROTERENOL. ON WATER INTAKE OF
RATS
Study I
Twenty-four rats (300 to 350 g) were divided randomly
into four equal groups and weighed. Groups i to 3 received
yohimbine (Sigma Chemical Co.] SC at 250. 500 and 1000
p.g/kg respectively. Group 4 served as control group and was
injected SC with the distilled water vehicle.
Study 2
On the day of the study, 24 rats (250 to 300 g) were di-
vided into four equal groups and weighed. Groups 1,2. and 3
were administered 150, 300 and 600 /zg yohimbine/kg SC,
respectively, in combination with 10 _.g of isoproterenol/kg
SC. Group 4 received 10 tzg of isoproterenol/kg SC in com-
bination with the vehicle used to dissolve yohimbine.
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Study 3
After a lapse of one week, the rats from Study 2 were
used a second time. Study 3 was carried out identically to
Study 2 except that 25 p.g of isoproterenol/kg was adminis-
tered SC and the doses of yohimbine used were 250,500 and
1000 p.g/kg, SC. Treatments were randomized to assure that
the rats in this study did not receive the same treatment as in
Study 2.
Statistical analysis of data was carried out by means of a
one-way analysis of variance (Study I) and a two-way
analysis of variance (Studies 2 and 3) [10].
EXPERIMENT 2: EFFECT OF TOLAZOLINE ALONE, AND IN
COMBINATION WITH ISOPROTERENOL, ON WATER INTAKE OF
RATS
Study 1
Twenty-four naive rats (250 to 300 g) were divided ran-
domly into four equal groups. Groups I to 3 received to-
lazoline SC at 250,500 and 1000/zg/kg, respectively. Group 4
served as a control group and was injected with the vehicle
used to disssolve the tolazoline.
Study 2
Twenty-four naive rats (250--300 g) were divided ran-
domly into 4 equal groups. Groups !, 2 and 3 received 250,
500 and I000 _g of tolazoline/kg SC in combination with 15
p.g of isoproterenol/kg SC. Group 4 was administered 15 _g
of isoproterenol/kg SC, in combination with the vehicle used
to dissolve the tolazoline.
Study 3
After a lapse of one week, the rats used in Study 2 were
also used here. Study 3 was carried out identically to Study 2
excepting that 25/zg of isoproterenol/kg was administered
SC.
Statistical analysis of these studies was carried out as
described in Experiment 1.
EXPERIMENT 3: EFFECT OF YOH1MBINE ON ANGIOTENSIN II-
INDUCED WATER INTAKE IN RATS
Twenty-one naive female rats (220 to 250 g) were divided
into 3 equal groups. All 3 groups received angiotensin I1 (200
p.g/kg, SC). Groups l and 2 received in addition 150 and
300 p.g yohimbine/kg SC while Group 3 received an equal
volume of distilled water used to dissolve the yohimbine.
Statistical analysis of the results was carried out by a
one-way analysis of variance [10].
EXPERIMENT 4: EFFECT OF CENTRALLY ADMINISTERED
TOLAZOLINE AND YOHIMBINE ON ANGIOTENSIN II-INDUCED
DRINKING
Stud.v 1
Sixteen naive rats (225 to 275 g) were divided into two
equal groups. Each rat was surgically prepared with an in-
dwelling intracerebroventricular cannula. Using Equithesin
(1.5 ml/kg) for anesthesia and a Kopf stereotaxic instrument,
a 23 gauge stainless steel tube (11 mm long) with a wire
obturator was implanted to end at the dorsal part of the right
lateral cerebral ventricle. The cannula was secured with
skull screws and dental cement, and a post-operative re-
covery time of 1 week was allowed prior to testing.
TABLE 1
EFFECT OF YOHIMBINE (SC) ON WATER INTAKE OF FEMALE
RATS (6 PER GROUP) DURING TWO HOURS AFTER TREATMENT
Cumulative Water Intake
Mean (ml/kg body wt) during:
Experimental Body
Group wt. (g) I hr 2 hr
Control 320 +-- 5* 3.9 -+ 0.9 4.2 -+ 0.9
Yohimbine 306 _+ 4 4.0 - 1.2 4.9 _+ 1.2
(250/xg/kg)
Yohimbine 321 - 12 2.9 -+ 0.7 6.8 -,- 1.6
(500 _g/kg)
Yohimbine 322 -'- 6 2.0 -+ 0.8 3.6 +- 1.0
( 1000/.tg/kg)
*One standard error of mean.
lntracranial injections of either tolazoline (10 /_g/kg, 8
rats) or isotonic saline (8 rats) were performed with the
animals held gently in a towel. The wire obturator was re-
moved, and an injector cannula (11.5 cm long, 27 gauge)
inserted to protrude just beyond the end of the implanted
cannula, i.e., into the lumen of the ventricle. The inner tube
was connected, via PEI0 tubing, to a 25 /11 syringe. A 5/zl
volume was injected manually over a period of 5 to 10 sec.
The injector was removed 5 sec later, the obturator replaced,
and the animal placed immediately into an individual test
cage. Fifteen minutes later all rats were administered
angiotensin II at a dose of 150 p.g/kg SC. A preweighed bottle
of water was placed on each cage and water intakes were
measured at one-half and one hour after administration of
angiotensin I1.
Study 2
This study was identical to Study I except that 20/.tg of
tolazoline/kg was administered IVT and that there were four
rats per group.
Study 3
This study was also identical to Study i except that
yohimbine (300 p.g/kg) was administered 1VT and that there
were 5 rats per group.
RESULTS
Experiment
Yohimbine administered SC to rats at 250, 500 and 1000
_g/kg had no significant effect on water intake during either
the first or second hours after administration (Table 1).
When 300 p.g yohimbine/kg was administered in combi-
nation with 10 tzg of isoproterenol/kg, water intake during
the first hour increased significantly (,o<0.05) above that of
the group receiving only isoproterenol (Fig. 1). Although all
three groups treated with yohimbine had greater water in-
takes during the first and second hours than the group
treated with isoproterenol alone, the differences in water
intakes from control were not statistically significant save
only for the 300 p.g dose of yohimbine during the first hour.
When yohimbine was administered in combination with a
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FIG. I. The effect of graded doses of yohimbine on water intake in
response to 10/zg isoproterenol/kg is shown during the first and first
two hours after treatment. One standard error is set off at each
mean. *.0<0.05 compared with control (0 dose) group.
TABLE 2
EFFECT OF TOLAZOLINE (SC) ON WATER INTAKE OF FEMALE
RATS (6 PER GROUP) DURING 2 HOURS AFTER TREATMENT
Cumulative Water Intake
Mean (ml/kg body wt) during:
Experimental Body
Group wt. (g) ! hr 2 hr
Control 233 _+ 4* 1.2 _+0.3 2.4 -+ 0.7
Tolazoline 228 _+ 5 1.0 _+0.2 1.6 -+ 0.2
(250 #g/kg)
Tolazoline 234 _+ 6 I. 1 -+-+0.1 1.4 _+ I.I
(500 p.g/kg)
Tolazoline 242 _+ 8 1.5 _+0.4 1.8 - 0.4
( Iooo/xg/kg)
*One standard error of mean.
larger dose of isoproterenol (25 /.tg/kg), water intake of the
group receiving 500 _g/kg was significantly greater than that
of the control group. During the second hour, the water in-
takes of the groups receiving the two higher doses of yohim-
bine were significantly greater (p <0.01) than that of controls
receiving only isoproterenol (Fig. 2).
E.rperiment 2
Tolazoline administered SC to rats at 250, 500 and 1000
p.g/kg, SC had no significant effect on water intake during
either the first or second hours after administration (Ta-
ble 2).
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FIG. 2. The effecl of graded doses of yohimbine on water intake in
response to 25/.tg isoproterenol/kg is shown during the first and first
two hours after treatment. One standard error is set off at each
mean. **p<0.01 compared with control (0 dose) group.
When tolazoline was administered in combination with
15 _zg isoproterenol/kg, water intakes during the first and
second hours after treatment were significantly greater than
that of the group receiving only isoproterenol (Fig. 3). The
group receiving 250 #g tolazoline/kg had a water intake not
significantly different from the control group but signifi-
cantly different (p<0.01) from the group treated with 500/zg
of tolazoline/kg.
When tolazoline was administered in combination with
25 p.g isoproterenol/kg water intake of the control group was
only slightly greater than it was following administration of
15 _zg isoproterenol/kg (Fig. 4). Administration of tolazoline
increased water intake above that of the group receiving only
isoproterenol during both hours after treatment, but the in-
takes were significantly greater only during the second hour
and only for the group receiving 500/xg of tolazoline/kg.
Experiment 3
Administration of yohimbine increased the angiotensin
II-induced drinking response of rats (Fig. 5). Administration
of 300/zg of yohimbine/kg was accompanied by an increase
in water intake that was significantly (,o<0.05) greater than
that of the group administered angiotensin II alone. Water
intake during the first two hours after administration of
angiotensin I1 was only slightly greater than that observed
during the first hour. Thus, the major portion (85-95%) of the
two hour water intake occurred during the first hour of the
experiment. This was also the case in Experiments 1 and 2.
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FIG. 3. Effect of graded doses of tolazoline on water intake in re-
sponse to 15 #g isoproterenol/kg is shown during the first and first
two hours after treatment. One standard error is set off at each
mean. *p<0.05; **p<0.01 compared with control (0 dose) group.
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FIG. 5. Effect of graded doses of yohimbine on water intake in
response to 200/zg angiotensin ll/kg is shown during the first and
first two hours after treatment. One standard error is set offal each
mean. *p<0.01 compared with control (0 dose) group.
_28
_ 24
(1:
__ 20
16
_ _2
z
ISOPROTERENOL (25p(jlW(] b w, s c ) ÷
TOLAZOLINE
/ /
T - ir \
/ II \
? ..\
" \
\,
O 250 500 10(30
DOSE OF TOLA7OLINE
()Jg/kg S.C )
-" 2B -
E
24
o
_ 20
E- 121
i'
:2
T
/
/
/
/
/
/
/
/
/
/
0 250 5(30 I000
DOSE OF TOLAZOLINE
(_q/kg S C )
FIG. 4. Effect of graded doses of tolazoline on water intake in re-
sponse to 25 tzg isoproterenol/kg is shown during the first and first
two hours after treatment. One standard error is set off at each
mean. **p<0.01 compared with control (0 dose) group.
Experiment 4
Peripheral administration of angiotensin II was accom-
panied by a vigorous water intake that occurred within one-
half hour after treatment (Table 3). lntraventricular (IVT)
administration of tolazoline at either I0 or 20 #g/kg 15 min-
utes prior to angiotensin II had no significant effect on the
angiotensin II-induced drinking response. An additional ex-
periment in which yohimbine (300 p,g/kg) was administered
IVT 15 minutes prior to angiotensin I1 also failed to affect the
drinking response to peripherally administered angiotensin
II.
DISCUSSION
Clonidine, an _-adrenergic agonist, has been shown to
inhibit dipsogenic responses to administration of isoprotere-
nol, 5-hydroxytryptophan, angiotensin I1 and Pilocarpine. as
well as to administration of hypertonic saline and a 24 hour
period of dehydration [2, 3, 12]. Activation of oto-
adrenoreceptors by clonidine is reported to lead to depres-
sion of norepinephrine release by sympathetic nerves [11].
The mechanisms by which this may have inhibited the dip-
sogenic responses to angiotensin II, hypertonic saline and
dehydration, while not clearly understood, may be centrally
located. On the other hand, the inhibition of the drinking
response to isoproterenol, 5-hydroxytryptophan and
pilocarpine may be explained both by the ability of clonidine
to suppress cAMP formation peripherally and by its inhibi-
tory effect on the release of renin from the kidney [9].
Angiotensin II, formed as a result of administration of these
compounds, is believed to be the ultimate dipsogenic agent
for them [I].
Yohimbine and tolazoline are reported to be selective
presynaptic a.,-adrenoreceptor antagonists which are be-
lieved to facilitate the release of norepinephrine by sympa-
thetic nerves [11]. It was therefore of interest to determine
their effect on the dipsogenic response to acute administra-
tion of isoproterenol and angiotensin ii. Neither yohimbine
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TABLE 3
EFFECT OF INTRAVENTRICULAR ADMINISTRATION OF TOLAZOLINE AND
YOHIMBINE ON WATER INTAKE OF RATS INDUCED BY PERIPHERALLY
ADMINISTERED ANGIOTENSIN !I
Cumulative Water Intake
Mean (ml/kg body wt) during:
Experimental No. of Body
Group Rats wt. (g) 1 hr 2 hr
Study 1
Angiotensin ii 8 236 +_ I1" 19.6 +_ 2.5 20.1 _+2.4
(150 t_g/kg, SC)
Angiotensin 11
+Tolazoline 8 269 -+ 10 15.8 _+ 2.5 19.2 _+3.3
(10/zg/kg, IVT)
Study 2
Angiotensin 11 4 287 _+ 7 22.4 _+ 3.8 23.1 - 3.8
(150 p_g/kg, SC)
Angiotensin II
+Tolazoline 4 267 _+ 8 16.1 +_ 1.8 18.8 _+3.6
(20 p.g/kg, IVT)
Study 3
Angiotensin I1 5 289 -+ 10 13.6 _+ 1.0 14.8 _+0.8
(150/zg/kg, SC)
Angiotensin II
+Yohimbine 5 304 _+ 11 13.0 +_ 2.1 15.1 _+ 2.0
(300 p,g/kg, IVT)
*One standard error of mean.
nor tolazoline, administered alone in graded doses, had an
effect on water intake during two hours after treatment (Ta-
bles 1 and 2). Similar results have been reported by others
[4,6]. However, when administered with either isoproterenol
or angiotensin II. the dipsogenic response was augmented
(Figs. I-5). These results suggest that release of norepi-
nephrine may be important in modulating the response to
dipsogenic stimuli. Those substances that act to facilitate the
release of norepinephrine from sympathetic nerve endings,
such as a-adrenolytic compounds, may also facilitate the
drinking response to administered isoproterenol [1 I]. Such
an effect has been reported for phentolamine [7,8]. On the
other hand, those substances that act to attenuate the release
of norepinephrine from sympathetic nerve endings, such as
cionidine, inhibit the drinking response to isoproterenol. A
possibility exists that the c_.,-adrenoreceptor is involved with
thirst and drinking on a broader scale since all dipsogenic
stimuli tested thus far, whether of extracellular or cellular
origin, can be inhibited by clonidine [3].
a2-Adrenoreceptors which bind clonidine, yohimbine and
tolazoline with a relative high degree of selectivity are lo-
cated not only presynaptically but also postsynaptically in
the central nervous system and in some peripheral tissues.
Hence, it was important to determine whether centrally
(IVT) administered tolazoline and yohimbine could augment
the dipsogenic response to peripherally administered
angiotensin II. At the doses used, tolazoline and yohimbine
given IVT failed to augment the drinking response to
angiotensin II. We believe the doses of both compounds
were adequate. However, the possibility exists that the
compounds might not have had as ready access to their site
of action when administered IVT as when administered pe-
ripherally.
Alternatively, the results suggest that augmentation of the
release of norepinephrine from nerve endings peripherally
may be responsible for the enhanced drinking response to
treatment with tolazoline and yohimbine. Thus, augmented
release of norepinephrine could induce release of renin from
the kidneys and result in the formation of angiotensin 11 and
enhancement of the dipsogenic effect of exogenously ad-
ministered angiotensin I1. Evidence for this possibility must
await additional studies.
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